Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
Completed
Ironwood Pharmaceuticals, Inc.
Phase 2
2006-11-01
The primary purpose of this study is to evaluate the efficacy and safety of administration of
linaclotide acetate in patients with chronic constipation.
Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Completed
Ironwood Pharmaceuticals, Inc.
Phase 2
2007-04-01
The purpose of this study is to determine the safety, efficacy, and dose response of a range
of oral doses of linaclotide administered to patients meeting criteria for IBS-C.
Trial of Linaclotide in Patients With Chronic Constipation
Completed
Forest Laboratories
Phase 3
2008-08-01
The objective of this trial is to determine the efficacy and safety of linaclotide
administered to patients with chronic constipation (CC). The primary efficacy parameter is
the percentage of patients in each dosing group that meet the protocol definition for
Complete Spontaneous Bowel Movement (CSBM) Overall Responder.
Trial of Linaclotide in Patients With Chronic Constipation
Completed
Ironwood Pharmaceuticals, Inc.
Phase 3
2008-08-01
The objective of this trial is to determine the efficacy and safety of linaclotide
administered to patients with chronic constipation (CC). The primary efficacy parameter is
the percentage of patients in each dosing group that meet the protocol definition for
Complete Spontaneous Bowel Movement (CSBM) Overall Responder.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
